These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 13728206)

  • 1. [Nicotinic acid in the treatment of vascular diseases].
    NEIKES K
    Med Welt; 1960 Sep; 38():1977-84. PubMed ID: 13728206
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of inositol-nicotinic acid therapy in the treatment of blood circulation disorders].
    SCHOGER GA
    Z Rheumaforsch; 1959 Oct; 18():367-72. PubMed ID: 14443418
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences in the treatment of arterial and venous blood circulation disorders, including ulcus cruris, with a nicotinic acid-xanthine derivative].
    EHLERS G
    Z Haut Geschlechtskr; 1961 Dec; 31():310-22. PubMed ID: 13889481
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of the association of sodium citrate and sodium phosphate with nicotinic acid in various peripheral vascular diseases].
    DI CIO' AV; SCHTEINGART M; KLEIN L
    Clin Lat; 1953; 3(3-4):141-5. PubMed ID: 13172908
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of peripheral blood circulation disorders with acetylcholine, nicotinic acid derivatives and cholinesterase antagonists].
    HEGER N
    Wien Med Wochenschr; 1957 Jul; 107(28):590-2. PubMed ID: 13456550
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nicotinic acid therapy of peripheral circulatory disorders].
    VOLKMANN E
    Zentralbl Chir; 1953; 78(46):1972-8. PubMed ID: 13147430
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic effects of various nicotinic acid derivatives in peripheral & cerebral circulatory disorders].
    STEINKE HJ
    Zentralbl Chir; 1958; 83(7a):444-51; discussion 452-4. PubMed ID: 13558577
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of peripheral vascular diseases in tuberculous patients with progresin].
    FEINDT H
    Medizinische; 1957 Nov; 25(48):1795-7. PubMed ID: 13492985
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of associated sodium citrate and sodium phosphate with nicotinic acid in certain peripheral vascular diseases].
    DI CIO AV; SCHTEINGART M; KLEIN L
    Prensa Med Argent; 1952 Jul; 39(28):1566-70. PubMed ID: 14957727
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nicotinamide hydroiodide in the treatment of degenerative arterial diseases].
    GUAGLIANO G; STOPPANI L
    Minerva Med; 1957 Oct; 48(85):3544-8. PubMed ID: 13493209
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tetrahydrofurfuryl ester of nicotinic acid in the treatment of peripheral vascular diseases].
    ROMANO G; VINDIGNI E
    Gazz Med Ital; 1952 Dec; 111(12):330-8. PubMed ID: 13043810
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of peripheral circulation disorders with progresin].
    KREBS P
    Munch Med Wochenschr; 1957 May; 99(21):783-4. PubMed ID: 13440925
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical contribution to the treatment of peripheral circulation disorders with Complamine].
    FALK G; LERCHE W
    Med Monatsschr; 1961 Jan; 15():36-40. PubMed ID: 13698017
    [No Abstract]   [Full Text] [Related]  

  • 14. [The balneotherapeutic influence of nicotinic acid and sulfur on peripheral circulation].
    KYSELKA R
    Arch Phys Ther (Leipz); 1959; 11():404-9. PubMed ID: 14413084
    [No Abstract]   [Full Text] [Related]  

  • 15. [The hexa-nicotinic acid ester of m-inositol in the treatment of peripheral vascular diseases. Clinical results].
    MAGLIULO V; SERRA GC
    Minerva Med; 1961 May; 52():1832-8. PubMed ID: 13765270
    [No Abstract]   [Full Text] [Related]  

  • 16. [Several cases of peripheral vascular diseases treated with tetrahydrofurfurylic ester of nicotinic acid].
    VECCHI GP; RUBBIANI V
    Minerva Med; 1953 Apr; 44(30):975-87. PubMed ID: 13071968
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical contribution to the treatment of autonomic circulation disorders].
    HIRSCH W
    Med Klin; 1957 Aug; 52(35):1536-9. PubMed ID: 13482958
    [No Abstract]   [Full Text] [Related]  

  • 18. [The influence on peripheral circulation disorders and on blood cholesterol of a nicotinic acid derivative (ES 304), administered in high doses].
    SIEGENTHALER P
    Praxis; 1960 Jun; 49():616-20. PubMed ID: 14446484
    [No Abstract]   [Full Text] [Related]  

  • 19. [Magnesium nicotinate in arterial blood circulation disorders].
    MUTH HW
    Dtsch Med J; 1956 Sep; 7(15):563-5. PubMed ID: 13375304
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with the nicotinic acid ester of hydroxyethltheophylline (hesotin) in the treatment of cerebral & peripheral circulation disorders].
    BRUNNER F
    Wien Med Wochenschr; 1959 Jun; 109(23):484-5. PubMed ID: 13669483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.